Anoikis (detachment-induced apoptosis) prevents the survival of cells at inappropriate sites of the body and can therefore act as a barrier to metastasis. In a functionbased genome-wide screen, we have previously identified the neurotrophic tyrosine kinase receptor TrkB as a potent suppressor of anoikis. Consistently, activated TrkB oncogenically transforms non-malignant epithelial cells and causes them to invade and produce metastatic tumors in vivo. Overexpression of activated TrkB also results in morphological transformation, resembling epithelial-mesenchymal transition (EMT). E-cadherin, an important EMT regulator, and two E-cadherin repressors, Twist and Snail, are critical for these TrkB functions. As Snail has been shown to induce Zeb1, another E-cadherin repressor, we hypothesized that Zeb1 could be a TrkB target, too. We show here that Zeb1 is required for TrkB-induced EMT in epithelial cells, as RNAi-mediated knockdown of Zeb1 reverted the morphological changes induced by TrkB. Furthermore, Zeb1 is involved in TrkB-induced anoikis resistance, migration and invasion. In vivo, knockdown of Zeb1 strongly reduced TrkB-induced metastasis. Finally, epistasis experiments showed that Zeb1 acts downstream of Twist and Snail. We conclude that Zeb1 is required for several TrkB-induced effects in vitro and in vivo, including metastasis.
Introduction
Knowledge about the mechanism by which tumor cells succeed to invade surrounding tissues and grow out as secondary tumors may help to identify new anticancer therapies. Metastasis comprises multiple steps in which tumor cells need to overcome defined barriers (Gupta and Massague, 2006; Geiger and Peeper, 2009) . One of these barriers is formed by the basement membrane, which invading tumor cells need to cross to invade surrounding tissues or to intravasate into blood or lymphatic vessels. Epithelial-mesenchymal transition (EMT) is thought to have an important role in this process (Thiery, 2002; Christofori, 2006) . EMT denotes a process that makes epithelial cells loose their typical cell-cell contacts, thereby providing them with increased migratory skills. It is characterized by loss of several epithelial proteins, including E-cadherin, b-catenin and g-catenin. Often, this is accompanied by the gain of mesenchymal proteins like vimentin, fibronectin and smooth muscle actin (Huber et al., 2005) . Loss of E-cadherin is the major hallmark of EMT. In line with a role for EMT in cancer progression, E-cadherin is often lost in cancer tissues (reviewed in Schmalhofer et al., 2009) . Its loss can be achieved in multiple ways, for example, by upregulation of transcription factors that can repress E-cadherin transcription. These regulators, including E12/E47, Twist, Zeb1, Zeb2 and the Snail family members, bind to the E-boxes within the E-cadherin promoter and thereby prevent its transcription (Batlle et al., 2000; Cano et al., 2000; Perez-Moreno et al., 2001; Eger et al., 2005; Vesuna et al., 2008) . Accordingly, Twist has been shown to contribute to metastasis (Yang et al., 2004) . Also the Zeb and Snail family members are often found overexpressed in metastasizing tumors (reviewed in (Peinado et al., 2007) ).
Another barrier on their path to distant sites that tumor cells have to overcome is anoikis, or, apoptosis induced by loss of extracellular matrix contacts (Meredith et al., 1993; Frisch and Francis, 1994) . Anoikis prevents tumor cells to survive in unfamiliar environments, such as the bloodstream (Liotta and Kohn, 2004) . In vitro, this can be mimicked by the use of special cell culture dishes that prevent epithelial cells to attach, thus triggering anoikis. Previously, in a genome-wide screen for anoikis resistance genes, we identified the neurotrophic kinase receptor 2 (NTRK2/TrkB) as a potent anoikis suppressor (Douma et al., 2004) . Consistent with the importance of anoikis suppression in metastasis, cells expressing activated TrkB were both tumorigenic and metastatic when injected subcutaneously into nude mice. TrkB and its primary ligand, brain-derived neurotrophic factor (BDNF), have a crucial role in the nervous system, contributing to the development and survival of neurons (Klein et al., 1993; Ernfors et al., 1994) . Interestingly, TrkB has been reported to be overexpressed in several cancers, including prostate cancer (Dionne et al., 1998) , pancreatic cancer (Miknyoczki et al., 1999) and neuroblastoma (Nakagawara et al., 1994; Brodeur, 2003) . On the basis of these and our previous studies, TrkB has been proposed to be a potential therapeutic target (Geiger and Peeper, 2005; Desmet and Peeper, 2006) . Currently, some anti-TrkB agents are being developed for therapeutic use (Thiele et al., 2009) . Previously, we found that kinase activity is required for TrkB's tumorigenic and metastatic effects (Geiger and Peeper, 2007) . Furthermore, we observed that TrkB induces EMT-like transformation, and that E-cadherin is required for TrkB-induced EMT and anoikis resistance. In addition, TrkB functions, including metastasis, were dependent on a Twist-Snail axis, with Twist acting upstream of Snail (Smit et al., 2009) .
Snail has been found to act upstream of another transcription factor, Zeb1 (Guaita et al., 2002) . This zinc-finger transcription factor was initially identified as a transcriptional repressor of the immunoglobulin heavy chain enhancer in B-cells, acting through E-boxes (Genetta et al., 1994) . Zeb1 can also bind the CDH1 promoter, thereby repressing its transcription and deregulating the epithelial phenotype of breast cancer cells (Eger et al., 2005) . Zeb1 is overexpressed in several cancer types (reviewed in Vandewalle et al., 2009) . As Snail is a critical TrkB target, we reasoned that Zeb1 could participate in this signaling pathway, too. Therefore, the aim of this study was to examine the contribution of Zeb1 to TrkB-induced EMT and metastasis.
Results
Zeb1 is required for TrkB-induced EMT Consistent with our previous observations (Smit et al., 2009) , active TrkB induced an EMT-like transformation in rat epithelial (RK3E TB ) cells (Figure 1a ). In line with other evidence (Kupferman et al., 2010) , we refer to this morphological transformation as EMT. Searching for critical TrkB effectors, we observed that both the RNA and protein expression of the transcription factor Zeb1 are induced upon expression of ligand-activated TrkB (Figure 1b and c) .
To determine whether Zeb1 corresponds to a critical TrkB target, we depleted it from RK3E TB cells. To reduce the likelihood of RNAi off-target effects, we used two independent non-overlapping hairpins against Zeb1 and generated independent stable clonal cell lines for each hairpin (Figure 2a ). As expected, RK3E TB cells expressing control hairpin (sh-EGFP) appeared with a spindle-shaped morphology. By contrast, cells expressing an shRNA against Zeb1 had reverted towards a more epithelial phenotype (Figure 2b ). The epithelial phenotype of the RK3E TB -sh-Zeb1 cells correlated with a sharp increase in the expression of E-cadherin, back to the level seen in parental epithelial cells (Figure 2a ). In addition, E-cadherin was correctly localized at the adherens junctions (Figure 2c ). We silenced Zeb1 also in RIE-1 TB cells (rat intestinal epithelial cells expressing TrkB þ BDNF) and observed a similar epithelial phenotype and upregulation of E-cadherin (Supplementary Figure S1 ). These results demonstrate that Zeb1 is critical for TrkB-induced EMT, in two different epithelial cell strains.
Zeb1 is critical for TrkB-induced anoikis resistance, migration and invasion Depletion of Zeb1 in RK3E TB cells also significantly suppressed their capacity to resist anoikis (Figure 3a) . We next determined whether this reduction in anoikis resistance was due to cell death or to an effect on proliferation. Of note, while under normal adherent conditions we observed no effect of Zeb1 depletion on cell proliferation, it did result in a net decrease in cell number when placed in suspension (Figure 3b ). Consistent with this, in suspension, depletion of Zeb1 from RK3E TB cells caused an increase in the levels of cleaved caspase 3 (Figure 3c , left panel), whereas under adherent conditions silencing Zeb1 had no such effect (Figure 3c , right panel). As there is no requirement for Zeb1 for basal cell cycle functions (even though Zeb1 was depleted well below the levels seen in parental cells), these results indicate that Zeb1 is specifically required for TrkB-induced anoikis resistance.
EMT is often accompanied by an increased capacity to invade and migrate. Indeed, in addition to EMT and anoikis resistance, we found that Zeb1 is also required for TrkB-induced migration and invasion. Upon silencing of Zeb1 in RK3E TB cells, cells lost their migratory and invading abilities (Figures 4a and b ). These results demonstrate that Zeb1 is required for the ability of TrkB to mediate anoikis resistance, migration and invasion.
Zeb1 is insufficient to induce anoikis resistance and anchorage-independent growth To determine whether, conversely, Zeb1 overexpression is sufficient to drive anoikis resistance and anchorageindependent growth, we overexpressed it in RK3E cells. Although Zeb1 was able to downregulate E-cadherin (Supplementary Figure S2A) , Zeb1-expressing cells were not anoikis-resistant (Supplementary Figure S2B, C) . Furthermore, these cells were unable to form colonies in soft agar (Supplementary Figure S2D) . This is consistent with the effects seen for overexpression of Twist or Snail, neither of which was sufficient to cause anoikis resistance or produce colonies in soft agar (Supplementary Figure S2) .
In light of the observation that Zeb1, Twist and Snail are commonly induced in cancer cells (for example, in TrkB-expressing cells), it is well possible that they mediate overlapping yet distinct functions. This raises the possibility that they bring about significant effects only when expressed in conjunction. Triple overexpression suppressed the levels of E-cadherin (Supplementary Figure S2E) . However, simultaneous overexpression of Twist, Snail and Zeb1 failed to induce anoikis resistance (Supplementary Figure S2F) or growth in soft agar (Supplementary Figure S2G) . We conclude, therefore, that in the context of untransformed epithelial cells, Zeb1 is insufficient to induce anoikis resistance and anchorage-independent growth. As this was seen irrespective of the presence of the abundance of Twist and Snail, these results suggest that these three major EMT transcription factors require additional oncogenic events to fully expose their transforming activities. 
Zeb1 is required for TrkB-induced metastasis
To determine whether Zeb1 is required for TrkB-induced primary tumor growth, we injected the established shRNAexpressing RK3E TB cell lines subcutaneously into nude mice. In spite of the observation that in vitro, the two Zeb1 knockdown cell lines proliferated with indistinguishable kinetics (Figure 3b ), in one cell line (nr. 2) Zeb1 depletion delayed primary tumor growth ( Figure 5a ). However, this was not observed for the other cell line. Clone #2 showed an effect on tumor growth and, in line with this, a slightly better depletion compared with clone #1 (Supplementary Figure S3) . Previous studies have reported differential effects of Zeb1 expression on tumor growth Wellner et al., 2009) , which is consistent with these observations.
From our previous studies, we know that RK3E TB cells are able to form metastatic lesions in the lungs (Smit et al., 2009) . To characterize these lesions, we analyzed two epithelial and two mesenchymal markers. The metastatic lesions were negative for the epithelial markers E-cadherin and keratin (Supplementary Figure  S4) . Although the metastatic lesions were negative for the mesenchymal marker smooth muscle actin, they did express vimentin (Supplementary Figure S4) , suggesting that the lesions are mesenchymal-like. Next, we determined whether Zeb1 is required for TrkB-induced metastasis. To allow for a direct comparison of the metastatic capacity of parental and Zeb1-depleted RK3E TB cells, we killed the mice when the primary, subcutaneously injected, tumors had reached a similar size. We found that upon silencing of Zeb1 in RK3E
TB cells, their capacity to form pulmonary metastases was strongly decreased (Figure 5b ). This was observed not only for the Zeb1-depleted cell line that showed reduced primary tumor growth, but also the one that had an indistinguishable capacity to produce a primary tumor. We conclude, therefore, that Zeb1 is an indispensable factor for TrkB-induced metastasis.
TrkB-induced induction of Zeb1 is mediated by the MAPK pathway
We have demonstrated previously that TrkB induces Twist and EMT through activation of the mitigenactivated protein kinase (MAPK) pathway (Smit et al., 2009) . Therefore, we determined whether the MAPK pathway mediates also the TrkB-induced induction of Zeb1. Treatment of TrkB-expressing cells with the MEK inhibitor U0126 led to downregulation of both Twist and Zeb1 protein levels (Supplementary Figure S5) , demonstrating that the MAPK pathway corresponds to an indispensable route for TrkB to induce Zeb1.
Zeb1 acts downstream of Twist and Snail
While we have shown previously that Twist acts upstream of Snail, Guaita et al. (2002) demonstrated that Zeb1 acts downstream of Snail. To determine whether a Twist-Snail-Zeb1 axis exists and operates in the context of TrkB signaling, we analyzed the Zeb1 levels in RK3E TB cells that had been stably depleted of Twist or Snail (Smit et al., 2009) . These cells display an epithelial morphology and express E-cadherin levels comparable with those in parental cells (not expressing TrkB). We observed that Zeb1 is downregulated upon (Figures 6a and b) . This indicates that Zeb1 is expressed as a function of the presence of both Twist and Snail.
To examine whether Twist, Snail and Zeb1 act in an overlapping pathway, we performed genetic epistasis experiments. Zeb1 was ectopically expressed in RK3E TB cells that had first been stably depleted of either Twist or Snail. Upon Zeb1 expression, the morphology of the cells reverted into a more mesenchymal phenotype (Figure 6c ). This morphological change was accompanied by the downregulation of E-cadherin (Figure 6d ), corroborating our finding that Zeb1 acts downstream of both Twist and Snail. Furthermore, silencing of Zeb1 in RK3E cells overexpressing Snail resulted in upregulation of E-cadherin (Figure 6e ), demonstrating that Zeb1 is required for Snail-induced repression of E-cadherin.
The presence of three transcription factors in a single pathway predicts that they share a significant number of downstream effectors. To inspect this pathway in more depth, we investigated whether any overlap exists between the downstream targets of these transcription factors. We performed a series of gene-expression microarray analyses and defined all respective targets as those genes that are significantly deregulated by at least 1.5 fold by two independent hairpins (ArrayExpress accession number E-MTAB-456). Following these criteria, we found that, in the context of TrkB, 53 outliers were common amongst Twist, Snail and Zeb1 (Figure 6f and Supplementary Table S1 ). We can reject the hypothesis that the Twist, Snail and Zeb1 targets are mutually independent, because their overlap was not due to randomness (Po0.0001, after Bonferroni correction). These results strongly suggest that Zeb1 acts in a pathway acting downstream of the Twist-Snail axis to regulate metastasis. However, at the same time, these results indicate that Zeb1 targets 165 genes that are not targeted by the other two factors. Similarly, Twist and Snail target both overlapping and unique sets of genes. This implies that both overlapping and distinct functions between these transcription factors collaborate to establish a coordinated regulatory network regulating EMT.
Discussion
In this report, we show that Zeb1 is a critical TrkB target, being responsible for several TrkB-dependent functions, including EMT, anoikis resistance, migration and invasion, but is not required for basal cell cycle functions under adherent conditions. Furthermore, we show that Zeb1 is required for TrkB-induced metastasis. TB cells expressing shRNAs against Twist, Snail or Zeb1 were compared with reference RK3E TB -sh-EGFP cells. To define the outliers for the different genes, common outliers (Po0.01) between the two respective independent shRNAs were selected first. Subsequently, to determine the overlap between Twist, Snail and Zeb1 targets, 'common Twist outliers' were overlaid with 'common Snail outliers ' and 'common Zeb1' outliers. showed that PI(3) kinase contributes to TrkB signaling as well (including anoikis resistance; Douma et al., 2004) , in aggregate these data suggest a model in which TrkB activates multiple pathways, some of which critically depend on Zeb1 (Figure 7) .
Several reports have shown a correlation between Zeb1 expression and the aggressiveness of tumors, including those of endometrial (Spoelstra et al., 2006; Singh et al., 2008) , colon (Pena et al., 2005; Aigner et al., 2007b) , breast (Aigner et al., 2007a) , lung (Dohadwala et al., 2006) , gallbladder (Adachi et al., 2009) , ovarian (Bendoraite et al., 2010) and prostate origin (Graham et al., 2008) . In colon cancer, Zeb1 expression is linked to loss of the basement membrane, which correlates with increased metastasis (Spaderna et al., 2006) . More functional evidence of a critical role for Zeb1 in metastasis came from Spaderna et al. (2008) . They have shown by injecting colorectal cancer cell lines into the spleens of nude mice that Zeb1 is required for liver metastasis. Wellner et al. (2009) showed similar results using an orthotopic model of pancreatic cancer cells metastasizing to the stomach and spleen after intrapancreatic injection. They found that these cells had decreased metastatic potential upon Zeb1 silencing. In all of these systems, it has been unclear what the pathways were driving the metastatic process. Here, we extend these findings by using a genetically defined system, which is driven by a single oncogene (TrkB), and show that Zeb1 is required for lung metastases deriving from subcutaneous tumors.
Several studies have shown regulation of Zeb1 by microRNAs, in the context of a negative feedback loop (Bracken et al., 2008; Burk et al., 2008; Gregory et al., 2008; Park et al., 2008) . Extending these findings, Wellner et al. (2009) reported that Zeb1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. However, Spaderna et al. (2008) reported no effect on tumorigenic potential in their pancreatic cells with silenced Zeb1 . This discrepancy could be explained by the relative level of knockdown in the different cell lines used. Indeed, we observed that low expression levels of Zeb1 are sufficient to mediate TrkB-induced tumorigenesis; only when a near-complete knockdown was achieved, tumor growth was inhibited.
We have shown previously that, at least in the context of TrkB, Snail acts downstream of Twist (Smit et al., 2009) . Guaita et al. (2002) have reported that Snail transcriptionally induces Zeb1. Here, we extend these data and observe a functional relationship between Zeb1, Twist and Snail. Our epistasis experiments indicate that Zeb1 acts downstream of Twist and Snail in the rat epithelial cells. Consistently, we find that Zeb1, Twist and Snail share more than 50 gene targets, reinforcing the notion that a common signaling pathway exists that regulates TrkB-driven metastasis.
Zeb1 is known to repress E-cadherin transcription through interaction with CtBP (Postigo and Dean, 1999) . CtBP is a corepressor that is implicated in anoikis resistance (Grooteclaes and Frisch, 2000) . Although functional evidence supporting a role for CtBP or Zeb1 has been lacking, we show that Zeb1 is critical for TrkBinduced anoikis resistance. Specifically, Zeb1 depletion rendered cells in suspension more susceptible to apoptosis. However, when analyzed in a non-oncogenic cellular context, Zeb1 was insufficient to drive anoikis resistance and anchorage-independent growth. This is consistent with our observations for the transforming capacity of other major EMT transcription factors Twist and Snail. We show that these transcription factors, even when they were expressed alongside Zeb1, were unable to drive anoikis resistance and anchorageindependent growth. However, Snail is able to induce metastasis in an oncogenic cellular context (Yin et al., 2007; Kudo-Saito et al., 2009) . Interestingly, these cells grew slower upon injection, showing that Snail is specifically promoting metastasis and not tumorigenicity. Those studies did not address the anoikis sensitivity and anchorage dependency of these cells. Mani et al. (2008) have shown that overexpression of Twist and Snail alone can induce mammospheres in cultured HMLE cells. However, the tumorigenesis assays that they performed were in the context of oncogenic Ras V12 (Mani et al., 2008) , suggesting that, consistent with our observations, Twist or Snail are only weakly inducing oncogenic transformation.
In conclusion, we have shown that Zeb1 is a critical target for TrkB-driven metastasis, as well as for several discrete functions like EMT and anoikis resistance, which contribute to this process. With studies like the current one, we aim to increase our understanding of the pathways driving cancer, with the ultimate goal to identify novel targets for therapeutic intervention.
Materials and methods

Vector constructs
Mouse BDNF in pBH vector and mouse TrkB in MSCV-blast vector were described previously (Douma et al., 2004; Smit et al., 2009, respectively) . The shRNA against EGFP, with the target sequence 5 0 -GCTGACCCTGAAGTTCATC-3 0 , has also been described (Smit et al., 2009) . ShRNAs against Zeb1 were cloned into the pRS vector (Brummelkamp et al., 2002) . The following target sequences were used: sh-Zeb1 #1 5 0 -GGAAAGCGTTCAAGTACAA-3 0 and sh-Zeb1 #2 5 0 -GAAAGGCATTTAAACACAA-3 0 . The pQXCIN-Zeb1 construct was a kind gift from Dr Nakshatri (Chua et al., 2007) , pBP-Twist was a kind gift from R Weinberg (Yang et al., 2004) , pBP-HA-Twist was described previously (Smit et al., 2009 ) and pRV-ires-GFP-Snail-HA was a kind gift from A Munoz (Palmer et al., 2004) .
Cell culture and retroviral transductions RK3E, RIE-1 and Phoenix packaging cells were cultured in Dulbecco's modified Eagle's medium containing 9% fetal calf serum (Greiner, Alphen a/d Rijn, The Netherlands). Virus production was carried out as described (http://www.stanford. edu/group/nolan/retroviral_systems/phx.html). To establish RK3E and RIE-1 cells expressing TrkB and BDNF (from hereon referred to as RK3E TB and RIE TB ) and expressing sh-EGFP or sh-Zeb1, the cells were first transduced with pBH-BDNF and selected with hygromycin. Subsequently, RK3E-BDNF cells were transduced with virus expressing either control hairpin (sh-EGFP) or sh-Zeb1, and selected with puromycin. After selection, cells were transduced with MSCV-TrkB virus and seeded at low density into medium with blasticidin selection, to allow clones to grow out (only for RK3E cells). For Twist and Snail overexpression, RK3E cells were transduced with pBP-Twist or pRV-ires-GFP-Snail-HA viral supernatant, and subsequently selected with puromycin (for Twist) or subjected to fluorescence-activated cell sorting (for Snail). For Zeb1 overexpression, RK3E or RK3E TB cells expressing sh-Snail or sh-Twist (described in Smit et al., 2009) were transduced with pQXCIN-Zeb1 three times, and cells were analyzed within a week after the first transduction.
Anoikis, soft agar, migration and invasion assays For anoikis assays, cells were trypsinized and 400 000 cells (for scans) or 1 000 000 cells (for quantification and western blot analysis) were seeded into six-well ultra-low cluster plates (Costar, Amsterdam, The Netherlands). After 4 days, scans were taken and cells were harvested. Cell pellets were lysed in RIPA buffer (50 mM Tris (pH 8.0), 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS) and protein content was determined with a Bio-Rad protein assay (BioRad, Veenendaal, The Netherlands). To measure the growth of the cells in suspension, 2000 cells were seeded into 96 wellultra-low cluster plates. The number of viable cells was determined daily by a cell titer blue assay (Promega, Leiden, The Netherlands). Fluorescence was measured with a TECAN infinite M200 scanner (Tecan, Giessen, The Netherlands). For soft agar assays, cells were trypsinized and 25 000 cells were seeded into 0.4% low-melting point agarose (Sigma, Zwijndrecht, The Netherlands) on top of a 1% agarose layer. After 2 weeks, scans were taken. For cell migration and invasion assays, cells were trypsinized and 250 000 cells were seeded onto control inserts (for migration) or in matrigel (for invasion) in medium without FCS. After one day of migration towards a serum gradient, migrated cells were stained with crystal violet. For quantification, five representative pictures were taken and the number of migrated cells was counted. Statistical analysis was performed with a Student's t-test.
Pharmalogical inhibition of mitogen-activated protein kinase (MAPK) pathway Cells expressing TrkB and BDNF were treated with 20 mM U0126 (Cell Signaling Technology, Leiden, The Netherlands) for 24 h and harvested. Cells were lysed in the presence of phosphatase inhibitors (1 mM sodium pyrophosphate, 2 mM sodium fluoride, 10 mM beta-glycophosphate and 2 mM sodium orthovanate) and treated as described in the western blot analysis section.
Western blot analysis
Cells were lysed in RIPA buffer and protein concentration was determined using Bio Rad assay. Samples were loaded onto 4-12% bis-tris precast gels (Nupage, Invitrogen, Breda, The Netherlands), transferred to nitrocellulose membranes (Whatman, GE Healthcare, Hoevelaken, The Netherlands) and blocked in 5% Protifar. Membranes were incubated with the following primary antibodies: E-cadherin (36E, BD Biosciences, Breda, The Netherlands), pan-Trk (C14, Santa Cruz, Heidelberg, Germany), BDNF (N20, Santa Cruz), b-actin (AC74, Sigma), Zeb1 (H102, Santa Cruz), Twist (Twist2C1a, Abcam, Cambridge, UK), Snail (hybridoma supernatant Sn9H2 from K. Becker (Rosivatz et al., 2006) ) and cleaved caspase 3 (Asp175, Cell Signaling). Proteins were visualized using ECL reagent (GE Healthcare).
Immunofluorescence Cells were seeded onto glass 8-well chambers and grown for 2 days to allow them to become confluent. Cells were fixed in formaldehyde, permeabilized in 0.2% triton and blocked in 5% normal goat serum. They were subsequently incubated with primary antibody mouse anti-E-cadherin (36E, BD Biosciences), washed and incubated with secondary antibody (goat anti-mouse Alexa488). Samples were washed, stained with TO-PRO and mounted in aqua polymount (Polysciences, Epperheim, Germany). They were analyzed with a Leica TCS NT (Leica Microsystems, Heidelberg, Germany). Images were taken with a Â 100 NA 1.32 objective using standard filters and Kalman averaging.
Quantitative RT-PCR RNA was isolated from cells in Trizol (Invitrogen). Quantitative RT-PCR was performed on cDNA obtained using standard protocol with oligo dT and reverse transcriptase II (Invitrogen). RNA levels were normalized against rat TATA box binding protein (TBP) RNA. Primers used were: TBP forward 5 0 -GATGTGAAGTTCCCCATAAGGC-3 0 , TBP reverse 5 0 -TCTGGCTCATAGCTACTGAACTGC-3 0 , Zeb1 forward 5 0 -ACAAATATGAGCACACAGGTAAGA GG-3 0 and Zeb1 reverse 5 0 -ATGCCTTTCTACAGATTCCA CACTC-3 0 .
Tumorigenicity and metastasis experiments
Balb/c nude mice that were 6-9 weeks of age were subcutaneously injected with 100 000 cells into both flanks. Mice were inspected twice a week for tumor formation and the size of the tumors was measured with a caliper. When tumors reached a diameter of 15 mm, mice were killed by CO 2 . Macroscopic lesions on the surface of the lungs were counted. Tumors and lungs were also examined by hematoxylin and eosin staining.
Immunohistochemistry staining
Immunohistochemistry staining was performed according to common procedures. For antigen retrieval, samples were incubated in 20 mg/ml proteinase K (Z0622, Sigma; for keratin WS, DakoCytomation, Heverlee, Belgium), in citrate buffer (Biogenex, Duiven, The Netherlands for E-cadherin) or in Tris-EDTA pH 9.0 (for vimentin). Antibodies used were: E-cadherin (36E, BD Biosciences), keratin WS (DakoCytomation), smooth muscle actin (Thermo Scientific, Etten-Leur, The Netherlands) and vimentin (Abcam). Sections were counterstained with hematoxylin.
Microarray experiments
Microarray analysis was performed on total RNA labeled with either CY 3 or CY 5 . The RNA was subsequently hybridized to Rat 4 Â whole genome oligo-arrays (Agilent, Amstelveen, The Netherlands). A dye swap was performed for each experiment. RK3E TB cells expressing shRNAs against Twist, Snail and Zeb1
were compared with a reference RK3E TB cell line expressing control shRNA against EGFP. We selected the outliers by applying a threshold of Po0.01 significance level and at least 1.5 fold regulation. To define the outliers for the different genes, common outliers, which were regulated in the same direction, between the two independent shRNAs were selected first. Subsequently, to determine the overlap between Twist, Snail and Zeb1 targets, common Twist outliers were overlaid with common Snail outliers and common Zeb1 outliers. A w
